These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 28965335)
21. Is the use of ecstasy and hallucinogens increasing? Results from a community study. Schuster P; Lieb R; Lamertz C; Wittchen HU Eur Addict Res; 1998 Mar; 4(1-2):75-82. PubMed ID: 9740820 [TBL] [Abstract][Full Text] [Related]
22. [Prevalence of psychiatric disorders in French general practice using the patient health questionnaire: comparison with GP case-recognition and psychotropic medication prescription]. Norton J; de Roquefeuil G; David M; Boulenger JP; Ritchie K; Mann A Encephale; 2009 Dec; 35(6):560-9. PubMed ID: 20004287 [TBL] [Abstract][Full Text] [Related]
23. Pregabalin Abuse amongst Opioid Substitution Treatment Patients. McNamara S; Stokes S; Kilduff R; Shine A Ir Med J; 2015; 108(10):309-10. PubMed ID: 26817289 [TBL] [Abstract][Full Text] [Related]
24. Psychological and physical impact of anabolic-androgenic steroid dependence. Ip EJ; Lu DH; Barnett MJ; Tenerowicz MJ; Vo JC; Perry PJ Pharmacotherapy; 2012 Oct; 32(10):910-9. PubMed ID: 23033230 [TBL] [Abstract][Full Text] [Related]
25. Illicit drug use and dependence in a New Zealand birth cohort. Boden JM; Fergusson DM; Horwood LJ Aust N Z J Psychiatry; 2006 Feb; 40(2):156-63. PubMed ID: 16476134 [TBL] [Abstract][Full Text] [Related]
26. Abuse Potential of Pregabalin: A Systematic Review. Schjerning O; Rosenzweig M; Pottegård A; Damkier P; Nielsen J CNS Drugs; 2016 Jan; 30(1):9-25. PubMed ID: 26767525 [TBL] [Abstract][Full Text] [Related]
27. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting]. Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408 [TBL] [Abstract][Full Text] [Related]
28. A survey of patients with substance use disorders at government treatment facilities in the Bahamas. Christie K; Clarke N; Frankson M West Indian Med J; 2013 Sep; 62(7):610-4. PubMed ID: 24831898 [TBL] [Abstract][Full Text] [Related]
29. Drug misuse and diversion in adults prescribed anxiolytics and sedatives. McLarnon ME; Monaghan TL; Stewart SH; Barrett SP Pharmacotherapy; 2011 Mar; 31(3):262-72. PubMed ID: 21361736 [TBL] [Abstract][Full Text] [Related]
30. [Analysis of addictive behaviours among new prisoners in France using the OPPIDUM program]. Pauly V; Frauger E; Rouby F; Sirere S; Monier S; Paulet C; Gibaga V; Micallef J; Thirion X Encephale; 2010 Apr; 36(2):122-31. PubMed ID: 20434629 [TBL] [Abstract][Full Text] [Related]
31. Illicit-drug injection among psychiatric patients without a primary substance use disorder. Horwath E; Cournos F; McKinnon K; Guido JR; Herman R Psychiatr Serv; 1996 Feb; 47(2):181-5. PubMed ID: 8825256 [TBL] [Abstract][Full Text] [Related]
32. Is depersonalization disorder initiated by illicit drug use any different? A survey of 394 adults. Simeon D; Kozin DS; Segal K; Lerch B J Clin Psychiatry; 2009 Oct; 70(10):1358-64. PubMed ID: 19538903 [TBL] [Abstract][Full Text] [Related]
33. Patterns and correlates of new psychoactive substance use in a sample of Australian high school students. Champion KE; Teesson M; Newton NC Drug Alcohol Rev; 2016 May; 35(3):338-44. PubMed ID: 26194894 [TBL] [Abstract][Full Text] [Related]
34. Behavioral dependence in patients with medication overuse headache: a cross-sectional study in consulting patients using the DSM-IV criteria. Radat F; Creac'h C; Guegan-Massardier E; Mick G; Guy N; Fabre N; Giraud P; Nachit-Ouinekh F; Lantéri-Minet M Headache; 2008 Jul; 48(7):1026-36. PubMed ID: 18081820 [TBL] [Abstract][Full Text] [Related]
35. [The use of cannabis in the Federal Republic of Germany]. Tossmann P Prax Kinderpsychol Kinderpsychiatr; 2006; 55(7):509-19. PubMed ID: 17058777 [TBL] [Abstract][Full Text] [Related]
36. Do users of regularly prescribed opioids have higher rates of substance use problems than nonusers? Edlund MJ; Sullivan M; Steffick D; Harris KM; Wells KB Pain Med; 2007; 8(8):647-56. PubMed ID: 18028043 [TBL] [Abstract][Full Text] [Related]
37. National population size estimation of illicit drug users through the network scale-up method in 2013 in Iran. Nikfarjam A; Shokoohi M; Shahesmaeili A; Haghdoost AA; Baneshi MR; Haji-Maghsoudi S; Rastegari A; Nasehi AA; Memaryan N; Tarjoman T Int J Drug Policy; 2016 May; 31():147-52. PubMed ID: 26980349 [TBL] [Abstract][Full Text] [Related]
38. New psychoactive substances as part of polydrug abuse within opioid maintenance treatment revealed by comprehensive high-resolution mass spectrometric urine drug screening. Heikman P; Sundström M; Pelander A; Ojanperä I Hum Psychopharmacol; 2016 Jan; 31(1):44-52. PubMed ID: 26763789 [TBL] [Abstract][Full Text] [Related]
39. Inpatient staff perceptions in providing care to individuals with co-occurring mental health problems and illicit substance use. Howard V; Holmshaw J J Psychiatr Ment Health Nurs; 2010 Dec; 17(10):862-72. PubMed ID: 21078001 [TBL] [Abstract][Full Text] [Related]
40. The 3-Year Course of Multiple Substance Use Disorders in the United States: A National Longitudinal Study. McCabe SE; West BT J Clin Psychiatry; 2017 May; 78(5):e537-e544. PubMed ID: 28406266 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]